The Nation - News from April 5, 1985
Preliminary tests show that a new drug can begin dissolving blood clots that cause heart attacks immediately after injection and is nearly twice as effective as medication now used, according to a study. The genetically engineered drug, called tissue-type plasminogen activator, dissolved most of the offending clots in 66% of the 120 patients tested, when injected into bloodstreams within a few hours of their heart attacks, the New England Journal of Medicine reported.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
